celecoxib has been researched along with Hemolysis in 6 studies
Hemolysis: The destruction of ERYTHROCYTES by many different causal agents such as antibodies, bacteria, chemicals, temperature, and changes in tonicity.
| Excerpt | Relevance | Reference |
|---|---|---|
| "This paper aims at demonstrating silk fibroin nanoparticles (SFNs) promote anti-inflammatory properties of celecoxib (CXB) or curcumin (CUR), and could be exploited for osteoarthritis (OA) treatment." | 7.91 | Silk fibroin nanoparticles for celecoxib and curcumin delivery: ROS-scavenging and anti-inflammatory activities in an in vitro model of osteoarthritis. ( Bari, E; Catenacci, L; Crivelli, B; Faragò, S; Mocchi, M; Perteghella, S; Prina-Mello, A; Sorrenti, M; Torre, ML; Tripodo, G, 2019) |
| "This paper aims at demonstrating silk fibroin nanoparticles (SFNs) promote anti-inflammatory properties of celecoxib (CXB) or curcumin (CUR), and could be exploited for osteoarthritis (OA) treatment." | 3.91 | Silk fibroin nanoparticles for celecoxib and curcumin delivery: ROS-scavenging and anti-inflammatory activities in an in vitro model of osteoarthritis. ( Bari, E; Catenacci, L; Crivelli, B; Faragò, S; Mocchi, M; Perteghella, S; Prina-Mello, A; Sorrenti, M; Torre, ML; Tripodo, G, 2019) |
| " All synthesized new compounds along with compound III as a parent compound and Celecoxib as a reference, were assessed for their antiinflammatory activity both in-vivo and in-vitro using the formalin-induced hind paw edema method and inhibition of albumin denaturation and Red Blood Cells (RBCs) membrane stabilization, respectively." | 3.88 | Synthesis, In-vivo and In-vitro Anti-inflammatory Evaluation of some Novel Coumarin Derivatives. ( Al-Wabli, R; El-Haggar, R; Fouad, M, 2018) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 4 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wu, F | 1 |
| Yi, Y | 1 |
| Sun, P | 1 |
| Zhang, D | 1 |
| Dube, PN | 1 |
| Bule, SS | 1 |
| Mokale, SN | 1 |
| Kumbhare, MR | 1 |
| Dighe, PR | 1 |
| Ushir, YV | 1 |
| Al-Wabli, R | 1 |
| Fouad, M | 1 |
| El-Haggar, R | 1 |
| Crivelli, B | 1 |
| Bari, E | 1 |
| Perteghella, S | 1 |
| Catenacci, L | 1 |
| Sorrenti, M | 1 |
| Mocchi, M | 1 |
| Faragò, S | 1 |
| Tripodo, G | 1 |
| Prina-Mello, A | 1 |
| Torre, ML | 1 |
| Lupescu, A | 1 |
| Bissinger, R | 1 |
| Jilani, K | 1 |
| Lang, F | 1 |
| Arai, Y | 1 |
| Tanaka, K | 1 |
| Ushijima, H | 1 |
| Tomisato, W | 1 |
| Tsutsumi, S | 1 |
| Aburaya, M | 1 |
| Hoshino, T | 1 |
| Yokomizo, K | 1 |
| Suzuki, K | 1 |
| Katsu, T | 1 |
| Tsuchiya, T | 1 |
| Mizushima, T | 1 |
6 other studies available for celecoxib and Hemolysis
| Article | Year |
|---|---|
Synthesis, in vitro inhibitory activity towards COX-2 and haemolytic activity of derivatives of esculentoside A.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Cell Line; Cyclooxygenase 2; Cyclooxygenase 2 Inhi | 2007 |
Synthesis and biologic evaluation of substituted 5-methyl-2-phenyl-1H-pyrazol-3(2H)-one derivatives as selective COX-2 inhibitors: molecular docking study.
Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Binding Sites; Carrageenan; Catalytic Domain; Cyclo | 2014 |
Synthesis, In-vivo and In-vitro Anti-inflammatory Evaluation of some Novel Coumarin Derivatives.
Topics: Albumins; Animals; Anti-Inflammatory Agents; Celecoxib; Coumarins; Disease Models, Animal; Dose-Resp | 2018 |
Silk fibroin nanoparticles for celecoxib and curcumin delivery: ROS-scavenging and anti-inflammatory activities in an in vitro model of osteoarthritis.
Topics: Anti-Inflammatory Agents; Antioxidants; Celecoxib; Cell Survival; Cells, Cultured; Curcumin; Drug De | 2019 |
Triggering of suicidal erythrocyte death by celecoxib.
Topics: Apoptosis; Calcium; Celecoxib; Cell Size; Cells, Cultured; Cyclooxygenase 2 Inhibitors; Erythrocytes | 2013 |
Low direct cytotoxicity of nabumetone on gastric mucosal cells.
Topics: Administration, Oral; Animals; Anti-Inflammatory Agents, Non-Steroidal; Butanones; Celecoxib; Cell C | 2005 |